Salient is an excellent design with a fresh approach for the ever-changing Web. Integrated with Gantry 5, it is infinitely customizable, incredibly powerful, and remarkably simple.


About us

Who We Are

PET First is a prospective study of up-front PET/CT in guiding diagnostic interventions in investigating pulmonary nodules suspicious for lung cancer. We asked lead researcher David Fielding to offer some insight into the project and how HIRF is contributing to clinical innovation.

What is your project about? PET First is about improving testing of patients with lung nodules by redefining when a FDG PET scan is done in patients with a higher than average probability of lung cancer. We hope to see an improved patient experience through requiring fewer tests.
What drove you into this field of research?  PET scans are often done AFTER the first biopsy and show abnormalities which could have guided the original biopsies. This drove us to ask whether this process could be improved.
What role does HIRF play with the project? HIRF plays an integral role in the project as they facilitate the expedient PET scanning required and also complete a breath hold CT which allows for navigational software to be used in any subsequent bronchoscopy procedures.
What impact could this project have on the community? A change in practice leading to less invasive procedures for the patient and faster outcomes in the investigation of suspicious lung nodules.
What would you say are the more challenging/enjoyable aspects of research? Finding a dedicated time for research while still being involved in clinical duties can be a challenge.  The positive is seeing the improved patient outcomes happening in clinical practice because of the research.
How did you hear about HIRF? Through their collaboration with UQCCR and QIMR Berghofer.
Advice to anyone wishing to start a research project? Look at what is happening in your clinical space – what are the ways you would like to see patient experience improved?



Dr. David Fielding

Principal Investigate for the PET First Project

The National Imaging Facility is expanding to include HIRF.


To view the article please click here to visit the official NIF website.

A new pilot support scheme has been announced at HIRF!

The 2020 support scheme seeks to capture new ideas for innovative use of imaging in medicine.  Reflecting the increasing role of collaboration at an early stage of innovation, this round of the scheme seeks to support ideas that are already able to demonstrate a link with state-wide, national or international research teams.

You can download the application form as a PDF form here, or word document here.

Herston Imaging Research Facility celebrated 1300 MRI, 200 PET/CT and 350 PET MR scans in September!

Herston Imaging Research Facility (HIRF) is now home to a new 18 channel breast coil for MRI, which delivers brilliant image quality and is better able to visualise masses in dense tissue.
The HIRF team are thrilled to have this new equipment available for clinicians and researchers looking to further examine abnormalities found during mammogram or ultrasound.  Breast MRI is a valuable technique to help identify cancer in high-risk patients and can also determine the extent of a known cancer in the breast. This new coil will enhance our breast imaging research capabilities and allow us to participate in multi-site clinical trials.

If you have any queries about breast imaging or other research imaging projects, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

HIRF Christmas Closure 2019

HIRF will close from December 23rd 2019 to 6th January 2020.  

Any research scans will need to occur before or after these dates.

We hope you all have a happy and safe holiday during this time,

and come back rejuvenated for another great research year in 2020.

christmas tree lighting composition rs 

HIRF is now listed on the national research data base (  Each system has a unique identifier that can be used in the methods section of research publications.

PETCT: 10378.3/8085/1018.17040

PETMR:  10378.3/8085/1018.17039

3T MRI:  10378.3/8085/1018.17038